Diabetes, gender, and left ventricular structure in African-Americans: The atherosclerosis risk in communities study

Cardiovascular Ultrasound

Volumn 4, Issue , 2006, Pages

  Foppa, Murilo ^a   Duncan, Bruce B ^a,b   Arnett, Donna K ^c   Benjamin, Emelia J ^d   Liebson, Philip R ^e   Manolio, Teri A ^f   Skelton, Thomas N ^g  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b IL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e RUSH MEDICAL COLLEGE   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g University of Mississippi Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE;

AFRICAN AMERICANS; AGED; ATHEROSCLEROSIS; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33751218311     PISSN: 14767120     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-4-43     Document Type: Article

References (38)

1. Galderisi M, Anderson KM, Wilson PWF, Levy D: Echocardiographic evidence for a existence of a distinct cardiomyopathy (The Framingham Heart Study). Am J Cardiol 1991, 68:85-89.
2. Lee M, Gardin JM, Lynch JC, Smith V-E, Tracy RP, Savage PJ, Szklo M, Ward BJ: Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study. Am Heart J 1997, 133:36-43.
3. Vakili BA, Okin PM, Devereux RB: Prognostic implications of left ventricular hypertrophy. Am Heart J 2001, 141:334-341.
4. Liao Y, McGee DL, Cao G, Cooper RS: Black-white differences in disability and morbidity in the last years of life. Am J Epidemiol 1999, 149:1097-1103.
5. Levy D: Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988, 108:7-13.
6. Gardin JM, Arnold A, Gottdiener JS, Wong ND, Fried LP, Klopfenstein HS, O'Leary DH, Tracy R, Kronmal R: Left ventricular mass in the elderly. The Cardiovascular Health Study. Hypertension 1997, 29:1095-1103.
7. Devereux RB, Roman MJ, De Simone G, O'Grady MJ, Paranicas M, Yeh JL, Fabsitz RR, Howard BV: Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation 1997, 96:1416-1423.
8. Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, Grimm R, Stamler J: Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993, 87:476-486.
9. Zabalgoitia M, Ur Rahman SN, Haley WE, Oneschuk L, Yunis C, Lucas C, Yarows S, Krause L, Amerena J: Impact of ethnicity on left ventricular mass and relative wall thickness in essential hypertension. Am J Cardiol 1998, 81:412-417.
10. Fox E, Taylor H, Andrew M, Han H, Mohamed E, Garrison R, Skelton T: Body mass index and blood pressure influences on left ventricular mass and geometry in African Americans: The Atherosclerotic Risk In Communities (ARIC) Study. Hypertension 2004, 44:55-60.
11. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, Kitzman DW, Hopkins PN, Morgan D, Rao DC, et al.: Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation 2001, 103:102-107.
12. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G: Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003, 52:1799-1805.
13. Rohde LE, Zhi G, Aranki SF, Beckel NE, Lee RT, Reimold SC: Gender-associated differences in left ventricular geometry in patients with aortic valve disease and effect of distinct overload subsets. Am J Cardiol 1997, 80:475-480.
14. The ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. Am J Epidemiol 1989, 129:687-702.
15. Collaborative Studies Coordinating Center, University of North Carolina: ARIC study documents: manuals, visit 3 [http://www.cscc.unc.edu/aric/visit/ index.phtml?visit=3].
16. Dubois D, Dubois EF: A formula to estimate the aproximate surface area if height and weight be known. Arch Intern Med 1916, 17:863-871.
17. Sahn DJ, DeMaria A, Kisslo J, Weyman A: The committee on Mmode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic methods. Circulation 1978, 58:1072-1083.
18. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458.
19. De Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH: Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995, 25:1056-1062.
20. Skelton TN, Andrew ME, Arnett DK, Burchfiel CM, Garrison RJ, Samdarshi TE, Taylor HA, Hutchinson RG: Echocardiographic left ventricular mass in African-Americans: the Jackson cohort of the Atherosclerosis Risk in Communities Study. Echocardiography 2003, 20:111-120.
21. Ganau A, Devereux RB, Roman MJ, De Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992, 19:1550-1558.
22. Kleinbaun DG, Kupper LL, Muller KE: Applied regression analysis and mulitvariable methods Boston: PWS-Kent Publishing Company; 1988.
23. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Welty TK, Robbins DC, Fabsitz RR, Howard BV, Lee ET: Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart Study. Am Heart J 2001, 141:992-998.
24. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, Lorell BH: Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 1999, 34:264-273.
25. Schillaci G, Pirro M, Pucci G, Mannarino MR, Gemelli F, Siepi D, Vaudo G, Mannarino E: Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension 2006, 47(5):881-6.
26. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Howard BV: Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. Diabetes 2002, 51:1543-1547.
27. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, Nesto RW, Wilson PW, Vasan RS: Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003, 107:448-454.
28. Galvan AQ, Galetta F, Natali A, Muscelli E, Sironi AM, Cini G, Camastra S, Ferrannini E: Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans. Circulation 2000, 102:2233-2238.
29. Lee KW, Lip GY: Insulin resistance and vascular remodelling, in relation to left ventricular mass, geometry and function: an answer to LIFE? J Hum Hypertens 2003, 17:299-304.
30. Devereux RB, De Simone G, Palmieri V, Oberman A, Hopkins P, Kitzman DW, Rao DC, Arnett DK: Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: the HyperGEN study. Am J Hypertens 2002, 15:1029-1035.
31. Alpert MA, Terry BE, Kelly DL: Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol 1985, 55:783-786.
32. Schmidt MI, Duncan BB: Diabesity: an inflammatory metabolic condition. Clin Chem Lab Med 2003, 41:1120-1130.
33. Lips DJ, deWindt LJ, van Kraaij DJ, Doevendans PA: Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur Heart J 2003, 24:883-896.
34. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D'Agostino RB: Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003, 107:1486-1491.
35. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
36. Avendano GF, Agarwal RK, Bashey RI, Lyons MM, Soni BJ, Jyothirmayi GN, Regan TJ: Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes 1999, 48:1443-1447.
37. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
38. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987, 59:956-960.